韩国国家乳房植入物登记处试点研究:经验与教训
韩国乳房植入物登记处(K-BIR)于2020年启动,并由六所大学教学医院和四家私人诊所于2020年4月1日至7月31日开展试点研究。试点期间登记325例患者、451例手术和366个植入物,最常见手术为美容指征的隆乳术(30%),其次为直接植入乳房再造(27%),光滑硅胶植入物最常见(73%)。结论指出K-BIR的持续维护和发展需要有效数据集、强化的退出登记法律体系与个人数据保护、多种激励措施及电子平台。
要点
- 试点期间登记325例患者、451例手术、366个植入物。
- 最常见手术为美容指征隆乳术(30%),其次直接植入乳房再造(27%)。
- 光滑硅胶植入物为最常见类型(73%)。
核心结论
- K-BIR有潜力为乳房植入物的研究与上市后监测系统提供质量保证和结局,并增强患者安全。
- K-BIR的持续维护和发展需要有效数据集、强化的退出登记法律体系与个人数据保护、提高参与率的多种激励措施以及患者、制造商和临床医生易于访问的电子平台。
研究设计与样本
- K-BIR由韩国整形与重建外科医师学会与韩国食品医药品安全部合作于2020年启动,并开展试点研究。
- 试点数据集通过在线调查和会议构建,聚焦全球乳房装置登记处的最低数据集。
- 试点研究于2020年4月1日至2020年7月31日实施,纳入六所大学教学医院和四家私人诊所。
主要发现
- 试点期间共登记325例患者、451例手术和366个植入物。
- 登记的最常见手术为美容指征的隆乳术(30%),其次为直接植入乳房再造(27%)。
- 使用的植入物类型中光滑硅胶植入物最常见(73%)。
- 试点后反馈调查包括与实际手术相比的登记率、录入时间、录入困难原因及额外所需数据等问题。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To improve the safety and early detection of unexpected breast implant-related complications, the Korean Breast Implant Registry (K-BIR) was launched in 2020 in cooperation with the Korean Society of Plastic and Reconstructive Surgeons and the Korean Ministry of Food and Drug Safety, and a pilot study was conducted. OBJECTIVE: This article provides an overview of our pilot study and experiences of the K-BIR. METHODS: The dataset to be used in the pilot form of K-BIR was constructed by holding online surveys and meetings focusing on the global breast device registry's minimum dataset. A pilot study was implemented from April 1, 2020, to July 31, 2020, with six university teaching hospitals and four private clinics. RESULTS: During the pilot study period, 325 patients, 451 procedures, and 366 implants were entered into the K-BIR. The most common procedure registered was augmentation mammaplasty (30%) for cosmetic indications, followed by direct-to-implant breast reconstruction (27%). Smooth silicone implant was the most common type (73%) of implant used. A feedback survey after the pilot study included questions about the registration rate compared with an actual procedure, entry time, reasons for difficulty in entry, and additional data needed. CONCLUSIONS: The continuous maintenance and development of K-BIR will require an effective dataset, a strengthened legal system for an opt-out registry and personal data protection, various incentives for increasing participation rates, and an electronic platform that patients, manufacturers, and clinicians can easily access. K-BIR has the potential to provide quality assurance and outcomes for research and post-market surveillance systems for breast implants as well as methods for enhancing patient safety.
引用
- Song WJ, Kang SG, Seo BMF, et al. Pilot study of the Korean national breast implant registry: Experiences and lessons learned. J Plast Reconstr Aesthet Surg. 2022. PMID: 35151594. doi:10.1016/j.bjps.2022.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。